<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/SearchAction>
<http://www.genengnews.com/industry-updates/colucid-pharmaceuticals-details-phase-3-development-strategy-for-lasmiditan-to-address-major-unm/161813723/>